PR Newswire - Bridge Biotherapeutics to Present at the 43rd Annu...
SEONGNAM, South Korea and BOSTON, Dec. 30, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based in South Korea developing novel drugs for fibrosis and cancer,...
Read More

ภาษาไทย
English